Products
Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.
| Molecule | Drug Class / Mechanism | Oncology Type | Inquiry | |
|---|---|---|---|---|
Anamorelin |
Appetite Stimulant / Anabolic Agent | Both (Solid & Hematologic) | ||
|
Molecule
Anamorelin
Therapeutic Category
Supportive Care (Nutrition/Cachexia)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Appetite Stimulant / Anabolic Agent |
||||
Enobosarm |
Appetite Stimulant / Anabolic Agent | Both (Solid & Hematologic) | ||
|
Molecule
Enobosarm
Therapeutic Category
Supportive Care (Nutrition/Cachexia)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Appetite Stimulant / Anabolic Agent |
||||
Omega-3 Fatty Acid Supplements (Onc Nutrition) |
Appetite Stimulant / Anabolic Agent | Both (Solid & Hematologic) | ||
|
Molecule
Omega-3 Fatty Acid Supplements (Onc Nutrition)
Therapeutic Category
Supportive Care (Nutrition/Cachexia)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Appetite Stimulant / Anabolic Agent |
||||
Medical Cannabinoid (Dronabinol) |
Appetite Stimulant / Anabolic Agent | Both (Solid & Hematologic) | ||
|
Molecule
Medical Cannabinoid (Dronabinol)
Therapeutic Category
Supportive Care (Nutrition/Cachexia)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Appetite Stimulant / Anabolic Agent |
||||
Nabilone |
Appetite Stimulant / Anabolic Agent | Both (Solid & Hematologic) | ||
|
Molecule
Nabilone
Therapeutic Category
Supportive Care (Nutrition/Cachexia)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Appetite Stimulant / Anabolic Agent |
||||
Bavituximab |
TIM-3 / LAG-3 / TIGIT Inhibitor | Both (Solid & Hematologic) | ||
|
Molecule
Bavituximab
Therapeutic Category
Immunotherapy (Investigational Checkpoint)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
TIM-3 / LAG-3 / TIGIT Inhibitor |
||||
Cobolimab |
TIM-3 / LAG-3 / TIGIT Inhibitor | Both (Solid & Hematologic) | ||
|
Molecule
Cobolimab
Therapeutic Category
Immunotherapy (Investigational Checkpoint)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
TIM-3 / LAG-3 / TIGIT Inhibitor |
||||
Sabatolimab |
TIM-3 / LAG-3 / TIGIT Inhibitor | Both (Solid & Hematologic) | ||
|
Molecule
Sabatolimab
Therapeutic Category
Immunotherapy (Investigational Checkpoint)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
TIM-3 / LAG-3 / TIGIT Inhibitor |
||||
Eftilagimod Alfa |
TIM-3 / LAG-3 / TIGIT Inhibitor | Both (Solid & Hematologic) | ||
|
Molecule
Eftilagimod Alfa
Therapeutic Category
Immunotherapy (Investigational Checkpoint)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
TIM-3 / LAG-3 / TIGIT Inhibitor |
||||
Favezelimab |
TIM-3 / LAG-3 / TIGIT Inhibitor | Both (Solid & Hematologic) | ||
|
Molecule
Favezelimab
Therapeutic Category
Immunotherapy (Investigational Checkpoint)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
TIM-3 / LAG-3 / TIGIT Inhibitor |
||||
Domvanalimab |
TIM-3 / LAG-3 / TIGIT Inhibitor | Both (Solid & Hematologic) | ||
|
Molecule
Domvanalimab
Therapeutic Category
Immunotherapy (Investigational Checkpoint)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
TIM-3 / LAG-3 / TIGIT Inhibitor |
||||
Etigilimab |
TIM-3 / LAG-3 / TIGIT Inhibitor | Both (Solid & Hematologic) | ||
|
Molecule
Etigilimab
Therapeutic Category
Immunotherapy (Investigational Checkpoint)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
TIM-3 / LAG-3 / TIGIT Inhibitor |
||||
AnamorelinSupportive Care (Nutrition/Cachexia) |
|
|
Therapeutic Category
Supportive Care (Nutrition/Cachexia)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Appetite Stimulant / Anabolic Agent |
|
EnobosarmSupportive Care (Nutrition/Cachexia) |
|
|
Therapeutic Category
Supportive Care (Nutrition/Cachexia)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Appetite Stimulant / Anabolic Agent |
|
Omega-3 Fatty Acid Supplements (Onc Nutrition)Supportive Care (Nutrition/Cachexia) |
|
|
Therapeutic Category
Supportive Care (Nutrition/Cachexia)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Appetite Stimulant / Anabolic Agent |
|
Medical Cannabinoid (Dronabinol)Supportive Care (Nutrition/Cachexia) |
|
|
Therapeutic Category
Supportive Care (Nutrition/Cachexia)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Appetite Stimulant / Anabolic Agent |
|
NabiloneSupportive Care (Nutrition/Cachexia) |
|
|
Therapeutic Category
Supportive Care (Nutrition/Cachexia)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Appetite Stimulant / Anabolic Agent |
|
BavituximabImmunotherapy (Investigational Checkpoint) |
|
|
Therapeutic Category
Immunotherapy (Investigational Checkpoint)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
TIM-3 / LAG-3 / TIGIT Inhibitor |
|
CobolimabImmunotherapy (Investigational Checkpoint) |
|
|
Therapeutic Category
Immunotherapy (Investigational Checkpoint)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
TIM-3 / LAG-3 / TIGIT Inhibitor |
|
SabatolimabImmunotherapy (Investigational Checkpoint) |
|
|
Therapeutic Category
Immunotherapy (Investigational Checkpoint)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
TIM-3 / LAG-3 / TIGIT Inhibitor |
|
Eftilagimod AlfaImmunotherapy (Investigational Checkpoint) |
|
|
Therapeutic Category
Immunotherapy (Investigational Checkpoint)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
TIM-3 / LAG-3 / TIGIT Inhibitor |
|
FavezelimabImmunotherapy (Investigational Checkpoint) |
|
|
Therapeutic Category
Immunotherapy (Investigational Checkpoint)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
TIM-3 / LAG-3 / TIGIT Inhibitor |
|
DomvanalimabImmunotherapy (Investigational Checkpoint) |
|
|
Therapeutic Category
Immunotherapy (Investigational Checkpoint)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
TIM-3 / LAG-3 / TIGIT Inhibitor |
|
EtigilimabImmunotherapy (Investigational Checkpoint) |
|
|
Therapeutic Category
Immunotherapy (Investigational Checkpoint)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
TIM-3 / LAG-3 / TIGIT Inhibitor |
|